(Q56766158)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

A J Friedman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M D Hornstein

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 August 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

236-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

A comparison of nafarelin acetate and danazol in the treatment of endometriosis

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis. I. Efficacy results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Hormone treatment of endometriosis: the estrogen threshold hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Revised American Fertility Society classification of endometriosis: 1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Should perimenopausal women be screened for osteoporosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Cortical and trabecular bone mineral content in women with endometriosis: effect of gonadotropin-releasing hormone agonist and danazol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

The reproducibility of the revised American Fertility Society classification of endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2956090-7

10.1016/S0015-0282(16)56090-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8339817%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference